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Abstract
Background
Dengue virus (DENV) infection causes viral haemorrhagic fever that is characterized by ex-
tensive activation of the immune system. The aim of this study is to investigate the kinetics
of the transcriptome signature changes during the course of disease and the association of
genes in these signatures with clinical parameters.
Methodology/Principle Findings
Sequential whole blood samples from DENV infected patients in Jakarta were profiled using
affymetrix microarrays, which were analysed using principal component analysis, limma,
gene set analysis, and weighted gene co-expression network analysis. We show that time
since onset of disease, but not diagnosis, has a large impact on the blood transcriptome of
patients with non-severe dengue. Clinical diagnosis (according to the WHO classification)
does not associate with differential gene expression. Network analysis however, indicated
that the clinical markers platelet count, fibrinogen, albumin, IV fluid distributed per day and
liver enzymes SGOT and SGPT strongly correlate with gene modules that are enriched for
genes involved in the immune response. Overall, we see a shift in the transcriptome from
immunity and inflammation to repair and recovery during the course of a DENV infection.
Conclusions/Significance
Time since onset of disease associates with the shift in transcriptome signatures from im-
munity and inflammation to cell cycle and repair mechanisms in patients with non-severe
dengue. The strong association of time with blood transcriptome changes hampers both the
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discovery as well as the potential application of biomarkers in dengue. However, we identi-
fied gene expression modules that associate with key clinical parameters of dengue that re-
flect the systemic activity of disease during the course of infection. The expression level of
these gene modules may support earlier detection of disease progression as well as clinical
management of dengue.
Author Summary
An acute dengue virus infection usually starts with a febrile disease phase that can progress
to severe disease around the time fever abates (defervescence). Here we study dengue pa-
tients that were included very early after the onset of disease and carefully monitored in a
longitudinal cohort study. Our results show that time after the onset of disease has a major
impact on the transcriptome profile of patients with dengue, which is confirmed by com-
paring our results with three other dengue studies that included patients at different dis-
ease stages. There is a gradual shift in transcriptome profile from an ‘immunity &
inflammation’- to a ‘repair & recovery’ phenotype. Furthermore, the expression of gene
network modules could be linked to specific clinical parameters of dengue virus infection.
Platelet counts and the levels of fibrinogen and albumin are shown to be good markers for
the activity and timing of the disease, reflecting relevant biological processes in the patient.
In contrast, conventional WHO classification systems did not show any association with
any of the 25 gene modules identified and only yielded a few differentially expressed
genes. The expression level of gene modules specific for certain biological processes in
dengue support earlier detection of progression to severe disease and may improve
clinical management.
Introduction
Dengue virus (DENV) infection is endemic in South-East Asia and has a large impact on socie-
ty, both in terms of burden of disease as in economic costs [1]. DENV belongs to the Flaviviri-
dae family and consists of at least four serotypes: DENV-1,-2,-3 and -4. DENV infection has
been described as a triphasic disease in the 2009 WHO dengue case classification [2]. The dis-
ease starts with the febrile phase in which all patients suffer from fever and a flu-like disease
with general symptoms, such as fever, myalgia, arthralgia, headaches, and retro-orbital pain.
After 3–5 days, patients enter the critical phase of disease, characterized by resolution of fever.
The majority of patients with non-severe dengue recover in this phase, but some patients devel-
op severe symptoms, such as shock, haemorrhage, or organ impairment, and they are classified
as having severe dengue. Typical for the development of severe disease in the critical phase of
dengue is a rapid decrease in platelet count with a concomitant increase in haemo-concentra-
tion due to plasma leakage. The critical phase usually lasts 24–48 hours, after which patients
enter the recovery phase.
To investigate the underlying biological processes involved in DENV pathogenesis, several
studies have applied transcriptome profiling to cohorts of dengue patients [3–5]. Some studies
report that the acute (febrile) phase of dengue is characterized by an increased expression of
genes involved in immunity and inflammation [6,7]. In this phase, transcripts involved in the
innate immune response, in particular interferon induced genes and complement, are highly
upregulated [6,7]. Other studies report that the convalescent (critical/recovery) phase is
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characterized by increased abundance of transcripts involved in cell cycle and cell repair mech-
anisms [5,8]. For disease severity in the acute phase of dengue, it has been shown that interfer-
on-induced genes have a lower expression in patients with dengue shock syndrome (DSS)
compared to patients with uncomplicated dengue [4,6]. In contrast, genes induced by the acti-
vation of neutrophils showed an increased expression level in patients with DSS [3,9]. This sug-
gests that lower levels of interferon lead to impaired viral clearance and increased activation of
neutrophils results in enhanced immune activation, which could both contribute to the devel-
opment of severe dengue.
In this study, we investigated the biology of dengue pathogenesis over time in a cohort of
dengue patients from Jakarta, Indonesia, where dengue is endemic and incidence increases
during the rainy season [2]. Using a transcriptomics approach, we studied gene expression pat-
terns, focusing on the association with dengue-specific clinical markers over time. We quantify
the overlap of our data with results from other studies, focussing in particular on the stage of
dengue disease. Furthermore, we perform a network analysis that relates clinical parameters to
gene modules, offering potential markers for disease activity.
Methods
Ethics
The research ethics committee of the Faculty of Medicine, University of Indonesia in Jakarta,
Indonesia, approved this study. Patients were included after written informed consent. If pa-
tients were younger than 18 years written informed consent was obtained from the parent and/
or legal guardian. Data and samples were anonymized with a study number.
Clinical cohort
Between March and June 2010 all patients 14 years of age with a fever onset 48 hours be-
fore presentation and a clinical suspicion of dengue were recruited in community health cen-
ters (‘puskesmas’) in Jakarta, Indonesia. Blood was drawn and a NS1 antigen and IgM/IgG
antibody rapid test (SD Dengue Duo, Standard Diagnostics, inc, Korea) was performed. If test-
ed positive for NS1 and/or IgM, patients were admitted to the Cipto Mangunkusomo Hospital
in Jakarta for seven days. The admission was only dependent on a positive outcome from the
rapid test and not based on clinical disease severity. Clinical data were recorded daily with a
standard case report form. Blood samples were collected on every other day (including the day
of admission), both for clinical laboratory tests and for transcriptome profiling. At day 3, 5 and
7 of admission ultrasound examination was performed to investigate whether patients suffered
from ascites and/or pleural effusion. In this study, day 0 refers to the day of admission unless
stated otherwise. According to the inclusion criteria, onset of disease was less than 48 hours be-
fore admission. Patients were classified according to the 2009 WHO dengue case classification
[2]. Briefly, patients with fever and general symptoms were classified as non-severe dengue
without warning signs (WS-). Patients with one of the following warning signs were classified
as non-severe dengue with warning signs (WS+): abdominal pain, vomiting, minor mucosal
bleeding, pleural effusion, ascites and hepatomegaly. Patients with shock, respiratory distress,
severe bleeding and/or organ impairment were classified as severe dengue. Healthy controls
were matched to age, sex and socio-economic status and recruited in the same geographical
area as the study subjects.
Genomics and Dengue
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Laboratory diagnostics
Serology. All diagnostic assays were performed at the Department of Microbiology, Facul-
ty of Medicine, University of Indonesia, Jakarta. The diagnosis of the rapid test was confirmed
with detection of NS1 antigen (Panbio) and/or IgM antibodies (Focus diagnostics) and/or a
positive RT-PCR (see next section). IgM and IgG antibodies were determined in all collected
sequential samples. Patients with a positive IgG in the sample from day 3–4 after admission
were considered as secondary DENV infection, while patients with a negative IgG in this sam-
ple were considered as a primary DENV infection. In two patients viral RNA could not be de-
tected, but they were included, because these patients were NS1 and IgM positive.
Molecular diagnostics. Reverse transcriptase PCR (RT-PCR) was performed to determine
the infecting serotype according to the method described in Lanciotti et al [10]. RNA was ex-
tracted from 140 μl of plasma using QIAamp viral RNA mini kit (Qiagen, Germany) according
to the manufacturer’s instruction. RNA isolation and PCR were performed in strict contain-
ment to avoid contamination. Negative controls were included in both RNA isolation and in
RT-PCR.
A semi-nested RT-PCR was performed for serotyping. The first amplification reaction had
a reaction volume of 40 μl, consisting of 4 μl 10x PCR buffer with 1.5 mMMgCl2, 3.2 μl 10mM
dNTPs, 0.4 μl Super Script II RTase (Invitrogen), 0.15μl 5 U Platinum Taq-polymerase (Invi-
trogen), 0.8 μl 10 μMD1 primer, 0.8 μl 10 μMD2 primer, 8 μl RNA. The RT step consisted
of 53°C for 30 minutes and denaturation at 95°C for 5 minutes. This was followed by 30 cycles
of denaturation at 95°C for 45 seconds, annealing at 60°C for 30 seconds, and extension at
72°C for 90 seconds. The RT-PCR was concluded with a single cycle extension at 72°C for
7 minutes.
The second PCR amplification had a reaction volume of 25μl, consisting of 2.5μl 10x PCR
buffer with 1.5 mMMgCl2, 2.0 μl 10 mM dNTPs, 0.15μl 5 U/μl Platinum Taq-polymerase
(Invitrogen), 1μl of each D1, TS1, TS2, TS3, TS4 primer (10 μM), 2μl of the product from the
first PCR. PCR 2 was performed with initial denaturation at 95°C for 5 minutes, followed by 35
cycles of denaturation at 95°C for 45 seconds, annealing at 60°C for 30 seconds, extension at
72°C for 60 seconds and one final single cycle extension at 72°C for 7 minutes.
After amplification, PCR products were analysed by electrophoresis. Eight μl of PCR prod-
uct was loaded on 2% agarose gel in TAE buffer and stained with Ethidium Bromide. The prod-
uct was visualized with UV light.
Blood transcriptome profiling. Blood was collected in Tempus Blood RNA tubes (ABI,
Foster city, CA, USA). Total RNA was isolated from whole blood using the Tempus Spin RNA
isolation kit (Applied Biosystems, Bleiswijk, The Netherlands). Globin RNA was removed
from total RNA preparations using the Globiclear kit (Life Technologies). RNA concentrations
and OD 260/280 ratios were measured with the NanoDrop ND-1000 UV-VIS spectrophotom-
eter (NanoDrop Technologies, Wilmington,USA). Assessment of RNA quality and purity was
performed with the RNA 6000 Nano assay on the Agilent 2100 Bioanalyzer (Agilent Technolo-
gies, Palo Alto, CA, USA). RNA (100 ng) was labelled using the MessageAmp Premier RNA
Amplication kit (Applied Biosystems) and hybridized to Human Genome U133 plus 2 gene
chips (Affymetrix), according to the manufacturer’s recommendations. Image analysis was
performed using GeneChip Operating Software (Affymetrix). Microarray Suite version 5.0
software (Affymetrix) was used to generate .dat and .cel files for each experiment. The raw data
has been deposited in the arrayExpress database under access number E-MTAB-3162.
Data normalization and analysis. Analysis of the arrays was performed using R 2.15/Bio-
conductor [11,12]. Gene expression was evaluated using alternative probeset definitions based
on the ensembl genome probeset annotation that yield a single probeset per gene. After quality
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control and VSN normalization [13–15], probeset summarization was performed by median
polish (i.e., RMA). Differential gene expression and Reactome pathway analysis was performed
using Limma and the Roast routine [11,16]. Limma fits a linear model for every gene and tests
for differential expression. The t-statistics are then moderated using an empirical Bayes-ap-
proach. Roast uses a similar approach to perform a self-contained gene set test for gene sets.
Significance for gene sets is computed by a bootstrapping approach (n = 10000). Multiple test-
ing correction (FDR< 0.05) is applied to both differential gene lists as well as differential
pathway lists.
Network construction. We applied weighted gene correlation network analysis
(WGCNA) using the available R libraries [17]. This method constructs a continuous correla-
tion network with a scale-free network topology. Our pre-processing approach yielded single
probeset-gene pairs with no ‘absent calls’ for any gene (see previous Methods section) that not
require any additional filtering. This allowed us to use all available probesets for network con-
struction and ensured that every gene was only included in the network once as a single node,
thereby providing an optimal approximation of the dengue transcriptional network structure.
This co-expression network was subsequently divided into modules using a topological overlap
distance measure and the dynamic tree cut algorithm. Gene modules are summarized by the
first principle component of the module, which can be correlated to parameters associated
with the cohort. External datasets were incorporated by using the list of differentially expressed
genes made available by the authors in the original paper.
Results
A longitudinal cohort of dengue patients
During the 2010 dengue outbreak in Jakarta, Indonesia, 157 patients were recruited into this
study. Of these patients, 52 were admitted to the hospital with a positive dengue IgM and/or
NS1 rapid test. All four dengue serotypes were circulating during this outbreak. Out of the 52
admitted patients, 26 patients were selected for blood transcriptome analysis based on the com-
pleteness of clinical data (i.e. symptoms, ultrasound data, laboratory parameters), and the avail-
ability of samples from day 0 and day 4 of admission and a confirmed laboratory diagnosis of
the rapid test for DENV infection (see Table 1 for clinical characteristics). During hospital ad-
mission, seven patients were diagnosed with WS-, eighteen with WS+ and one with severe den-
gue. The patient with severe dengue displayed signs of severe haemorrhage, including melaena.
No patients developed shock, although fifteen patients did receive a large amount of IV fluid
during their admission (more than 10 litres in total and one patient even 25 liters), indicating
that these patients were critically ill. Interestingly, the leukocyte count was not different be-
tween day 0 of admission (median 4070, (IQR: 2575–5380)) and day 4 (median: 3930, (IQR:
2495–5355)), although at day 0 the leukocyte count was lower in the WS+ group compared to
the WS- group, but this difference was not significant (Table 1). Fifteen age- and sex-matched
healthy controls from the same geographical location in Jakarta and similar socio-economic
status were also included in this study.
A maximum of three tempus tubes from each patient was included in this analysis. We in-
cluded a total of 61 tempus tubes from 26 patients. 20 tempus tubes were collected at day 0 of
admission (i.e., day 1–2 after onset of fever) and 20 at day 4 (i.e., day 4–5 after onset of fever);
these time points were therefore analysed in detail. An overview of the timepoints and disease
categories is provided in S1 Table.
Genomics and Dengue
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Time since admission accounts for most transcriptome variance
To obtain a global overview of the dengue transcriptome profiles, we applied principal compo-
nent analysis (PCA) (Fig. 1). This non-supervised analysis method finds the ‘optimal point of
view’ for observing differences between the samples and depicts this as a distance in a 2-dimen-
sional plot. The first principle component (PC1) accounts for 47% of the variance in the dataset
and concurs with time since admission. The second principle component (PC2) accounts for
17% of the variance in gene expression and segregated the dengue samples from the healthy
controls; together, PC1 and PC2 account for 64% of gene expression differences in the dataset.
PCA did not show any segregation of patients by disease severity according to the 2009 WHO
classification. Taken together, PCA demonstrates that time since admission has the highest im-
pact on the dengue transcriptome profiles in our cohort.
WS- andWS+ dengue patients have indistinguishable transcriptional
profiles
To obtain insight into the transcriptional changes that are associated with disease severity and
time since admission, we performed differential gene expression analysis and gene set analysis
in dengue patient and control transcriptomes (FDR 0.05 and fold change 2). We used the
2009 WHO dengue case classification system to group patients and excluded the single case
with severe disease from gene expression analysis. Combining data from all time points re-
vealed that 161 genes were up- and 73 genes were downregulated in WS- patients compared to
healthy controls (Fig. 2A, S1 Information). In WS+ dengue patients, 186 genes were up- and
Table 1. Clinical characteristics of the cohort.
2009 WHO dengue case
classiﬁcation
WS- (N = 7) WS+/severe (N = 19)
Sex (male/female) 3/4 11/8
Age* 20 (17–33) 19 (17–27)
Primary/secondary/unknown 2/4/1 6/13/0
Serotype (DENV-1/-2/-3/-4/not
detected)
3/2/1/0/1 2/6/7/3/1
Pleural effusion during admission
(US)
0 4 (21%)
Ascites during admission (US) 0 9 (47%)
IV ﬂuid during admission (ml)* 7000 (2000–
11000)
11000 (6000–13500)
Positive tourniquet at day of
admission
2 (33%)# 10 (53%)
Leukocyte count at admission* 6060# (2655–
7470)
4000 (2520–5150)
Thrombocytopenia during
admission
3 (50%)# 18 (95%)
Mucosal bleeding 0 6 (32%) (1 gum, 2 epistaxis, 2 gum and epistaxis,
1 melaena)
Vomiting during admission 0 6 (32%)
Abdominal pain during admission 0 12 (63%)
* Values are in median (interquartile range). Abbreviations: WS-: non-severe dengue without warning
signs. WS+: non-severe dengue with warning signs. # = 1 missing value in the WS- group in the tourniquet
test, platelet and leukocyte count.
doi:10.1371/journal.pntd.0003522.t001
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100 genes were downregulated relative to healthy controls. There is considerable overlap (216
genes) of differentially expressed genes in both dengue groups, suggesting that similar biologi-
cal processes are ongoing in both WS- and WS+ dengue patients. Indeed, no genes were differ-
entially expressed when comparing WS- to WS+ dengue patients directly. Next, the
transcriptome profiles of samples from day 0 and day 4 since admission were compared to
identify genes differentially expressed over time, regardless of disease severity (Fig. 2B,
Fig 1. Principle component analysis of all transcriptome snapshots in this study. Icons and colours indicate type and sampling stage of the samples.
Timing of samples range from day 0 to day 6 of admission. The day 0 samples have the lightest colour and the day 6 samples the darkest. All probesets were
included for this analysis.
doi:10.1371/journal.pntd.0003522.g001
Genomics and Dengue
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S1 Information). More genes were differentially expressed in time since admission than be-
tween WS- and WS+ disease, confirming the PCA results that time since admission has the
Fig 2. Differential gene expression analysis. Venn diagrams show the overlap between different sets of differentially expressed genes. FDR<0.05, all
differentially expressed genes are at least 2-fold up- or down-regulated.
doi:10.1371/journal.pntd.0003522.g002
Genomics and Dengue
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largest impact on the transcriptome. To study dengue disease effects independently of time
since admission, we restricted our analysis to transcriptome profiles fromWS-, WS+ and
healthy controls at day 0 and day 4 of admission. On day 0, many genes were differentially ex-
pressed in each of both dengue groups compared to healthy controls, but no genes were differ-
entially expressed when the severity groups were compared to each other (Fig. 2C). At day 4,
the number of differentially expressed genes in WS- and WS+ dengue compared to healthy
controls was lower than at day 0 (Fig. 2D, S1 Information). When severity groups were com-
pared at day 4, again no genes were differentially expressed. Taken together, in our study, WS-
andWS+ blood transcriptional profiles cannot be distinguished from each other.
Time since onset of disease explains discordant transcriptional
signatures in dengue patients
Over the past few years, several studies have examined the transcriptional profile of dengue in-
fections. Three cross-sectional studies (Tolfvenstam et al., Long et al. and Loke et al.) [6,7,18]
were similar in the type of sample used (whole blood) and the included data on time since
onset of symptoms, allowing these studies to be compared to results from our cohort (Fig. 3A,
Table 2). Tolfvenstam et al. and Long et al. have a fairly large overlap in differentially expressed
genes (Fig. 3D), presumably because both studies included patients early (<72 hours) after
onset of disease. The signatures published by Loke et al. have little overlap with those of the
other studies (1 and 5 genes only, Loke et al. DF and DHF signatures combined), most likely
Fig 3. Overlap of differential gene expression with signatures identified in other studies. (a) indicates
the signatures generated in this study, (d) those of the other dengue studies. (b-c) and (e-f) indicate the
overlap with the signatures of day 0 and day 4, respectively.
doi:10.1371/journal.pntd.0003522.g003
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due to the fact that patients were included at a later time point after the onset of disease (3–6
days after onset). To compare our results to these studies, we compared the early and late gen-
eral dengue signatures to those of the other studies. 48% of differentially expressed genes in the
signature from Tolfvenstam et al. and 63% of Long et al. are also part of our day 0 dengue gene
signature (collected<48 hours after onset of disease) (Fig. 3B). On the contrary, only 1% of the
genes in the DF and 7% of the genes in the DHF signature in Loke et al. were similar to our day
0 signature (Fig. 3C). In contrast, our day 4 signature showed the greatest similarity with the
signatures in Loke et al. (68% DF, 68% DHF; Fig. 3F), but much less so with those from Tolf-
venstam et al. and Long et al. (18% and 35%, respectively; Fig. 3E). Our results therefore concur
with all three studies and confirm that these signatures can occur within one cohort, but at dif-
ferent time points after onset of symptoms. In conclusion, time since the onset of symptoms ac-
counts for most of the transcriptome differences between mRNA profiling studies in
dengue patients.
The dengue transcriptome shifts from an immunity and inflammation—to
a repair and recovery signature
The type I interferon pathway is known to be differentially expressed in DENV infection [19].
We investigated the interferon response during the course of infection by selecting genes from
the interferon pathway (Reactome curated pathway database, 57 genes) and plotting their ex-
pression over time (Fig. 4). The expression of the majority of interferon genes was highly in-
creased on the first day of admission, but decreased rapidly after that day and continued to be
low, consistent with the notion that the interferon pathway is active in the early stages of den-
gue infection [4].
To functionally annotate the differences in gene expression, we performed gene set analysis
using the Reactome curated pathway database [20]. Applying the Roast algorithm [21], we
found that when compared with healthy controls, both WS- and WS+ have ‘complement’ and
‘interferon signalling’ ranked among the most highly up-regulated pathways (Fig. 4, S2 Infor-
mation). None of the pathways were differentially regulated when comparing the WS- with the
WS+ patients.
In addition to severity signatures, we investigated the transcriptional changes related to
time since admission in our longitudinal cohort. By comparing day 0 dengue samples to
healthy control samples, we observed an up-regulation of pathways related to innate immunity
and cytokine signalling (Fig. 4, S2 Information). When we compared Day 4 to healthy controls,
a pronounced shift to cell cycle and DNA repair mechanisms was evident. A direct comparison
between day 0 and day 4 samples additionally showed up-regulation of metabolism (Fig. 4).
Taken together, we see that, initially, innate immunity and interferon is up-regulated, followed
by repair mechanisms that mark the beginning of recovery from dengue.
Table 2. Characteristics of studies proﬁling whole blood of DENV infected patients.
Study Loke et al. Long et al. Tolfvenstam et al.
Journal PloS Neglected Tropical Diseases Journal of Virology BMC Infectious Diseases
Year 2010 2010 2011
Country Nicaragua Vietnam Singapore
Population Children < 15 years Adults and children Adults
Day of illness Between 3–6 days <72 hours <72 hours
doi:10.1371/journal.pntd.0003522.t002
Genomics and Dengue
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Classical dengue clinical parameters associated with transcriptional
patterns in dengue
Next, we investigated the association between the identified gene modules and clinical parame-
ters. To this end, we used weighted gene correlation network analysis (WGCNA) that organizes
genes into 25 modules that are subsequently correlated to 18 clinical parameters (Fig. 5, S3 In-
formation). This analysis confirms that time since admission has a strong effect on the tran-
scriptome of dengue patients and that immune-related genes dominate the early response.
Significant associations between gene modules and the clinical parameters platelet count, fi-
brinogen level, albumin level and volume of IV fluid per day were found. Most modules that
displayed a positive correlation with time after admission also did so with the quantity of IV
fluid and the liver enzyme SGOT. These same modules displayed a negative association with
the platelet count and levels of fibrinogen and albumin. Platelets, albumin and fibrinogen are
all part of the blood compartment in which dengue targets monocytic cells to replicate [22].
The pro-inflammatory environment due to DENV replication probably affects the expression
of these markers. This may explain the association of these markers with these gene modules.
In contrast to the above-mentioned clinical parameters, the 1997 WHO dengue case classifi-
cation as well as the 2009 WHO dengue case classification showed no significant association
with any of the gene modules, suggesting that these classifications do not reflect the underlying
biological processes, or that there are no differences in the underlying biological processes. The
non-specific warning signs ‘abdominal pain’ and ‘vomiting’ showed no statistical significant as-
sociations, which is in line with the generic nature of these symptoms. In contrast, DENV-spe-
cific warning signs including ‘epistaxis’ and ‘gum bleeding’ did correlate with the gene modules
Fig 4. Gene set analysis of dengue signatures. The interferon pathway (left panel) is upregulated in the early stages of dengue, but not later. Segment
plots indicate the significance of enrichment of particular Reactome gene sets and pathways. The longer the segment, the larger the enrichment. All
segments longer than the grey segment are significant.
doi:10.1371/journal.pntd.0003522.g004
Genomics and Dengue
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B-antiquewhite4, O-brown4, M-salmon4 and W-sienna3. Enriched GO terms for genes in the
O-brown4 module are “cell organelles”, such as mitochondrion and cytoplasm. Module W-si-
enna3 has wound healing and coagulation as enriched GO terms and module M-salmon4 is re-
lated to catabolic processes. Ascites, which is a typical sign of plasma leakage, is significantly
associated with modules G-palevioletred3 and P-yellowgreen. These two gene modules were
not associated with time, suggesting that this is a specific biological pathway. All in all, network
analysis showed that the WHO classifications couldn’t be related to specific gene modules;
however, there are many significant correlations between gene modules and dengue-specific
clinical parameters.
Specific genes correlate with the platelet count and the liver enzyme
SGOT
In order to identify genes that may serve as a marker of immune activation in the early phase
of disease, we focused on modules with a strong negative correlation with time after admission.
Fig 5. Dengue co-expression network analysis. Significant correlations between gene modules (y-axis) and clinical parameters (x-axis) are depicted in a
red-to-green colour scale. Upper number is pearson correlation coefficient, lower number the level of significance (p-value). All gene modules are annotated
with gene enrichment categories; clinical parameters are grouped by symptom type.
doi:10.1371/journal.pntd.0003522.g005
Genomics and Dengue
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These modules contain genes that are upregulated specifically in the earliest phase of disease
that could represent biomarkers for disease progression, including modules M-salmon4, R-
cyan, T-lightyellow, U-orange, and X-darkorange. By correlating genes contained in these
modules with clinical parameters that mark disease severity, genes associated with can be iden-
tified. Five genes in the module T-lightyellow showed a significant direct association with the
platelet count (Fig. 6), including two that play a role in immunological processes. The IL-18 re-
ceptor accessory protein (IL-18RAP, Fig. 6A) forms the receptor complex with IL-18Rα and is
needed for IL-18 signalling. Cytidine deaminase (CDD, gene CDA) is highly expressed by acti-
vated granulocytes and serves as a negative feedback mechanism of these cells by inhibiting the
function of granulocyte-macrophage colony formation in the bone marrow [23] (Fig. 6B).
KCNJ15 and G-protein coupled receptor 27 (GPR27) (Fig. 6C-D) are both described to play a
role in insulin secretion [24,25]. In the module X-darkorange, the gene Tropomodulin 1
(TMOD1) was directly associated with the platelet count (Fig. 6E) and the genes Mical2 and
dematin (gene EBP49) with SGOT (Fig. 6F-G) all play a role in actin regulation of the cell [26–
28]. Seven other genes with an inverse association with SGOT play a role in metabolic
Fig 6. Correlations between genes (y axis) and clinical parameters (x-axis).Genes are annotated with a gene symbol; those depicted in (a-d) are from
module T-lightyellow; (e-j) are frommodule X-darkorange. Icons depict the class of the sample (see Fig. 1). Spearman’s Rho correlations and p-values are
given in the plot.
doi:10.1371/journal.pntd.0003522.g006
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processes, including sestrin 3 (SESN3), adiponectin receptor 1 (ADIPOR1) and STE20-related
kinase adaptor beta (STRADB) (Fig. 6H-J). Sestrin 3 is required for regulation of the blood glu-
cose levels [29] and sestrins can reduce the levels of reactive oxygen and protect cells against
cell death [30]. Adiponectin acts through the adiponectin receptor 1, which results in increased
fatty acid oxidation in the liver [31]. Adiponectin activates serine/threonine kinase 1 via its re-
ceptor (LKB1) [31]. Interestingly, the gene STE20-related kinase adaptor beta was also signifi-
cantly associated with the SGOT and is part of a complex involved in the activation of LKB-1.
LKB-1 is important in maintaining cell polarity of hepatocytes, which is essential in the forma-
tion and maintenance of the bile canalicular network [32]. In summary, we find genes that cor-
relate with clinical parameters and that can be related to either dengue pathogenesis or tissue
physiology, suggesting that these genes may be directly associated with the ongoing biological
processes in dengue infection.
Discussion
In this study, we examined DENV infected patients with uncomplicated disease using tran-
scriptome profiling. By using a variety of analysis techniques, we show that time since admis-
sion, which is a proxy for time since onset of disease, is the most important determinant of the
blood transcriptome profile changes in DENV infected patients. Regardless of the analysis
techniques used, we did not observe differences in blood transcriptional profiles between WS-
andWS+ patients. Conversely, the clinical parameters platelet count, albumin, fibrinogen,
SGOT, SGPT and volume of IV fluid administered showed a highly significant association with
specific gene modules. Gene module expression may serve as a novel marker to monitor the bi-
ological processes involved in dengue pathogenesis.
A recurring theme in our results is that time after the onset of disease is the main determi-
nant of transcriptome profile changes in DENV infected patients. This observation is in line
with the results reported by Sun et al., although PBMCs were used in that study [5]. Moreover,
the comparison of our data to signatures published by Loke et al., Long et al. and Tolfvenstam
et al. show that stratifying the expression data by time after onset of disease results in a large
overlap with these gene expression profiles. These studies performed transcriptome profiling in
unrelated cohorts from populations of patients with diverse genetic backgrounds, geographical
locations and age distributions, demonstrating that the impact of time since onset of disease on
gene expression is a general and robust feature of DENV infection.
In contrast to the strong signal related to time since onset of disease, there was no detectable
transcriptional difference between WS- and WS+ patients. Earlier studies showed that gene ex-
pression patterns from patients with DSS did segregate from those of DF and DHF patients
[9,18]. This is the first time that the 2009 WHO classification was used in transcriptome analy-
sis, but our results extend other studies showing that no clear distinction can be made between
the transcriptome profile of DF and DHF samples [9,18,33]. This conclusion is based on differ-
ential gene expression and co-expression network analysis of dengue transcriptome data that
both take all available genes into account; it is therefore unlikely that this is due to a gene inclu-
sion bias during the analysis phase. The fact that no differentially expressed genes could be
identified in comparisons between WS- and WS+ dengue suggests that the biological processes
in these two disease entities are very similar or that the generated blood transcriptome profiles
do not accurately reflect disease processes in other parts of the body. The latter is not expected
given that DENV infection is a systemic disease that targets monocytic cells in the blood com-
partment [22]. Our network analysis showed that epistaxis, gum bleeding and ascites were as-
sociated with gene modules distinct from those that associate with markers reflecting systemic
disease, such as platelet count, fibrinogen, albumin and IV-fluid, suggesting that these markers
Genomics and Dengue
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003522 March 13, 2015 14 / 20
reflect different biological processes. The network analysis also showed that the parameters
platelet count, fibrinogen, albumin and IV fluid reflect the processes of systemic immune acti-
vation and subsequent repair mechanisms in the blood. We conclude that distinct dengue-re-
lated signatures can be identified, but that these do not concur with the comprehensive WS-
andWS+ categories in dengue diagnosis. Furthermore, if WS-/WS+ specific biomarkers could
be identified, the strong effect of time upon infection on transcriptome dynamics would limit
the application of such biomarkers in a clinical setting. However, the expression level of the
identified gene modules specific for biological processes relevant in dengue disease may sup-
port earlier detection of progress to severe disease and improve clinical management
of dengue.
The clinical parameter platelet count has frequently been associated with DENV infection
[34] and was even one of the four criteria for DHF in the 1997 WHO dengue case classification
[35]. It has been shown that children with lower platelet counts in the early phase of disease are
more likely to develop DHF later on [36]. Several hypotheses to link DENV infection with
platelet depletion have been postulated, such as DENV induced bone marrow suppression
[37], complement-induced lysis of platelets through the binding of autoantibodies [38] or the
binding of platelets to activated endothelial cells [39]. Our study finds, besides an association
between the platelet count and certain gene modules, a strong activation of the innate immuni-
ty and complement, which could contribute to all these three mechanisms of platelet depletion.
Furthermore, we found that expression of IL-18RAP, which is involved in the induction of
IFN-γ production in NK and Th1 cells [40], to be directly associated with the platelet count.
Fagundes et al. showed that IL-18 signalling was necessary to inhibit viral replication in DENV
infected mice and that IL-18 knock-out mice showed increased virus titres and more severe dis-
ease [41].
The occurrence of plasma leakage in dengue patients has been extensively documented. We
observe that markers of plasma leakage, including the quantity of IV-fluid supplied and the lev-
els of albumin, were both associated with the same gene modules as platelet count. Plasma leak-
age tends to correlate inversely with the platelet count [42] and it has been suggested that
platelets may directly induce vascular permeability by the release of IL-1β [43]. Albumin is
strongly negatively charged, which prevents leakage from the circulation under normal condi-
tions. However, decreased levels of albumin have been detected in patients with DSS, suggest-
ing that selective restriction by the endothelial barrier is impaired during DENV infection,
resulting in leakage of albumin from the circulation to the tissue [44]. In different cohorts of
patients, we showed that dengue shock syndrome and a pro-inflammatory cytokine profile
were strongly associated with microbial translocation and the presence of lipopolysaccharide
(LPS) in the blood, suggesting that plasma leakage is the result of immune activation during
DENV infection [45]. In this study, we find that the R-cyan module is strongly associated with
albumin concentration and plasma leakage; the module’s contents show an association with
pro-inflammatory cytokines of the interferon response, as well as upregulation of the TLR-4
pathway that detects LPS. This result is in line with our previous observations [45,46], that link
pro-inflammatory cytokines profiles, microbial translocation and plasma leakage in
DENV infection.
In severe dengue, dysregulation of coagulation is frequently observed. Fibrinogen is con-
sumed after thrombin generation and decreased levels have been detected in severe dengue
[47]. The strong association of fibrinogen with gene modules involved in immunity and in-
flammation suggests that activation of the coagulation cascade is associated with the strong im-
mune response in the acute phase of DENV infection. It has been shown that activation of the
coagulation cascade can induce the production of cytokines through NF-κB activation [48],
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indicating that crosstalk between coagulation and inflammation may contribute significantly
to disease severity.
In our study, gene modules were enriched for metabolic and catabolic processes, kinase ac-
tivity and organelles, such as mitochondria. Loke et al., also showed that many upregulated
genes in the acute phase were involved in metabolic processes and shared between acute DF,
DHF and DSS samples [18], suggesting that a highly activated metabolic state is part of the gen-
eral dengue signature. Acute DENV infection is also characterized by extensive activation of
the innate immune response, such as complement and neutrophils [5,7,49]. Complement is
suggested to be an important inhibitor of replication of Flaviviruses [50], and was among the
most highly overrepresented pathways in our study. Similarly, studies performed in whole
blood have shown that neutrophil-related genes are highly expressed in dengue expression sig-
natures that correlated with disease severity [3,9,18]. In our study, the neutrophil derived pro-
tein CDD associated with the platelet count, suggesting increased abundance in the acute
phase of disease. This protein could be associated with severe disease, because high levels of
CDD have also been shown in patients with meningococcal sepsis [51].
Our results indicate involvement of the liver in dengue pathogenesis. Especially the gene
modules involved in inflammation and immunity correlated with the liver enzymes SGOT and
SGPT, suggesting that dengue induced inflammation affects the liver. Moreover, ten individual
genes showed a significant association with the liver enzyme SGOT. The liver may be affected
directly by viral replication or indirectly by cytokines and immune cells. One surprising finding
from our study is differential regulation of several genes that play a role in diabetes. The genes
adiponectin receptor 1, sestrin 3, KCNJ15 and G-protein coupled receptor 27 have all been de-
scribed to play a role in insulin resistance, decreased insulin secretion and impaired blood glu-
cose homeostasis [24,25,52]. It has been shown that inflammation and certain cytokines in
particular lead to insulin resistance, which may result in further activation of multiple inflam-
matory processes [53,54]. In support of this finding, it has been shown that DENV infected pa-
tient with diabetes had a higher risk to develop severe disease [55,56]. Altogether, the above
suggests involvement of the liver in dengue pathogenesis, in particular related to insulin and
blood glucose regulation during DENV infection and pathogenesis.
Future studies should aim to carefully track time since the start of infection, as time is the
main source of variance in transcriptomes from dengue patients. Since the transcriptome ef-
fects in time are larger than potential transcriptome effects between severity classes, a synchro-
nous longitudinal cohort is an absolute requirement for any biomarker study. Furthermore,
individual symptoms and markers appear to better reflect the biological processes underlying
dengue pathogenesis. Classification on the basis of gene signatures related to specific symp-
toms, rather than overall diagnosis, may enable earlier identification of patient subgroups that
are at increased risk of developing severe dengue, and to a better understanding of dengue
disease pathogenesis.
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